ARADIGM CORP. ARDM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARADIGM CORP. ARDM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edwin Slonim who wrote (10)	6/4/1998 8:32:00 PM
From: Marvin Frank	Read Replies (1) of 255

Dear Edwin, Agree that ARDM stock should have responded to the new Novo deal but it is possible the analysts do not follow the stock that closely. The benefits of insulin administration through other routes than injection is nothing short of spectacular. The recent announcement seemed to indicate that ARDM is ahead of its competitors and we may see the inhalation therapy for insulin released the end of '99. I'm buying more.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next